SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-240014
Filing Date
2022-09-07
Accepted
2022-09-07 16:16:07
Documents
12
Period of Report
2022-09-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d367394d8k.htm   iXBRL 8-K 23892
  Complete submission text file 0001193125-22-240014.txt   141286

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bntc-20220906.xsd EX-101.SCH 2893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20220906_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20220906_pre.xml EX-101.PRE 10837
6 EXTRACTED XBRL INSTANCE DOCUMENT d367394d8k_htm.xml XML 3212
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 221231367
SIC: 2834 Pharmaceutical Preparations